Recursion Pharmaceuticals annual current ratio
2020
2021
2022
2023
2024
2025
Recursion Pharmaceuticals Current Ratio Growth & History (RXRX)
Recursion Pharmaceuticals's current ratio was 5.50 for fiscal 2025.
View full Recursion Pharmaceuticals company overviewRecursion Pharmaceuticals annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 5.50 | 1.69 | +44.44% |
| 2024 | 2024-12-31 | 3.81 | −0.89 | −18.98% |
| 2023 | 2023-12-31 | 4.70 | −0.98 | −17.25% |
| 2022 | 2022-12-31 | 5.68 | −5.78 | −50.41% |
| 2021 | 2021-12-31 | 11.46 | −0.07 | −0.64% |
| 2020 | 2020-12-31 | 11.53 | — | — |
Recursion Pharmaceuticals quarterly current ratio
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 5.03 | 1.45 | +40.62% |
| Q1 2026 | 2026-03-31 | 5.47 | 1.36 | +32.97% |
| Q4 2025 | 2025-12-31 | 5.50 | 1.69 | +44.44% |
| Q3 2025 | 2025-09-30 | 4.60 | 0.25 | +5.73% |
| Q2 2025 | 2025-06-30 | 3.58 | −2.49 | −41.01% |
| Q1 2025 | 2025-03-31 | 4.11 | −0.53 | −11.49% |
| Q4 2024 | 2024-12-31 | 3.81 | −0.89 | −18.98% |
| Q3 2024 | 2024-09-30 | 4.35 | −0.01 | −0.16% |
| Q2 2024 | 2024-06-30 | 6.07 | 2.29 | +60.44% |
| Q1 2024 | 2024-03-31 | 4.65 | −0.69 | −12.96% |
| Q4 2023 | 2023-12-31 | 4.70 | −0.98 | −17.25% |
| Q3 2023 | 2023-09-30 | 4.36 | −1.44 | −24.80% |
| Q2 2023 | 2023-06-30 | 3.78 | −1.87 | −33.05% |
| Q1 2023 | 2023-03-31 | 5.34 | −1.89 | −26.11% |
| Q4 2022 | 2022-12-31 | 5.68 | −5.78 | −50.41% |
| Q3 2022 | 2022-09-30 | 5.80 | −8.19 | −58.55% |
| Q2 2022 | 2022-06-30 | 5.65 | −16.27 | −74.23% |
| Q1 2022 | 2022-03-31 | 7.23 | −1.03 | −12.50% |
| Q4 2021 | 2021-12-31 | 11.46 | −0.07 | −0.64% |
| Q3 2021 | 2021-09-30 | 13.99 | — | — |
| Q2 2021 | 2021-06-30 | 21.92 | — | — |
| Q1 2021 | 2021-03-31 | 8.26 | — | — |
| Q4 2020 | 2020-12-31 | 11.53 | — | — |
Recursion Pharmaceuticals current ratio trends
Over the last five fiscal years, Recursion Pharmaceuticals's current ratio decreased from 11.53 to 5.50, a change of −6.03. The latest reported quarter, Q2 2026, shows 5.03.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Recursion Pharmaceuticals source filings ↗